Exploring TRIZ contradiction analysis in design for additive manufacturing: insights from expert interviews
Proceedings of the Design Society · 2026-08 · 6 · 1951-1960
DOI: 10.1017/pds.2026.10553 ↗Kurz gefasst
Fachartikel in der Zeitschrift Proceedings of the Design Society, online erschienen am 02.07.2026. Verfasst von Florian Günther und 5 weiteren Autor:innen. Die Arbeit nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
This paper examines whether the empirical knowledge of the TRIZ design theory is suitable for Design for Additive Manufacturing (DfAM). We systematically assess TRIZ engineering parameters (EP) and inventive principles (IP) in the context of contradiction analysis via DfAM, drawing on 11 semi-structured interviews. Findings indicate thematic alignment between DfAM methods and TRIZ IP, but reveal that the original TRIZ engineering parameters inadequately capture the multidimensional design space offered by DfAM. We outline directions to adapt the TRIZ EP for improved applicability.
Zitieren
APA
Günther, F., Schlegel, A. P., Adunka, R., Stengel, T., Goudriaan, A., & Koch, A. (2026). Exploring TRIZ contradiction analysis in design for additive manufacturing: insights from expert interviews. Proceedings of the Design Society, 6, 1951-1960. https://doi.org/10.1017/pds.2026.10553
Vancouver
Günther F, Schlegel AP, Adunka R, Stengel T, Goudriaan A, Koch A. Exploring TRIZ contradiction analysis in design for additive manufacturing: insights from expert interviews. Proceedings of the Design Society. 2026;6:1951-1960. doi:10.1017/pds.2026.10553
BibTeX
@article{Gnther2026,
author = {Günther, Florian and Schlegel, Alexander Patrick and Adunka, Robert and Stengel, Theresa and Goudriaan, André and Koch, Alexander},
title = {Exploring TRIZ contradiction analysis in design for additive manufacturing: insights from expert interviews},
journal = {Proceedings of the Design Society},
year = {2026},
volume = {6},
pages = {1951--1960},
doi = {10.1017/pds.2026.10553}
}
EUVIMED